# Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation

> **NCT00162487** · NA · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 150 (estimated)

## Conditions studied

- Hyperkalemia
- Chronic Renal Failure

## Interventions

- **DRUG:** Albuterol (1,200 μg) through metered-dose inhaler

## Key facts

- **NCT ID:** NCT00162487
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162487, "Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00162487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*